Huge Wins as BioTime Wins Geron IP and Star Scientific Thyroiditis Data Published
I hope you've had a pleasant holiday season. As this is the first alert of the new year, I'd like to talk about the two biggest developments of 2012. Coincidentally, both culminated in the last few days, which has me both very tired and very excited.
I suspect, by the way, that these two developments will maintain their ranking for years to come. They are BioTime's just-announced acquisition of Geron's massive stem cell patent library and the preliminary data from the Johns Hopkins thyroiditis study using Star Scientific's) nutraceutical anatabine citrate.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.